Successful outcomes of a new combined solution of hyaluronic acid, chondroitin sulfate and poloxamer 407 for submucosal injection: animal survival study
Background and study aims Endoscopic resection requires use of submucosal injection. This study was conducted to assess efficacy and impact on early healing of hyaluronic acid combined with chondroitin sulfate and poloxamer 407 (Ziverel) when used as a solution for submucosal injection. M...
Main Authors: | Henry Córdova, Miriam Cuatrecasas, Ana García-Rodríguez, Andrea Montenegro, Jordana Melo, Cristina Rodríguez-de Miguel, Graciela Martínez-Pallí, Rodrigo Garcés-Durán, Josep Llach, Gloria Fernández-Esparrach |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2019-04-01
|
Series: | Endoscopy International Open |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-0869-7757 |
Similar Items
-
Efficacy and safety of a combination of hyaluronic acid, chondroitin sulfate, and poloxamer 407 as a submucosal injection solution for endoscopic resection: pilot study on a swine model
by: G. Fernández-Esparrach, et al.
Published: (2017-05-01) -
Formulation and characterization of poloxamer 407®: thermoreversible gel containing polymeric microparticles and hyaluronic acid
by: Gabriela Garrastazu Pereira, et al.
Published: (2013-01-01) -
Thermogelling properties of purified poloxamer 407
by: Amir Fakhari, et al.
Published: (2017-08-01) -
Hyaluronic acid on the urokinase sustained release with a hydrogel system composed of poloxamer 407: HA/P407 hydrogel system for drug delivery.
by: Hao-Ying Hsieh, et al.
Published: (2020-01-01) -
Achieving sustain release of urokinase with a novel hydrogel system composed by poloxamer 407 and hyaluronic acid
by: Wei-Yang Lin, et al.
Published: (2018)